Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
NCT ID: NCT00999063
Last Updated: 2011-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4108 participants
OBSERVATIONAL
2009-12-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female or male aged at least 18 years
* Patient must be having symptoms suggestive of upper gastrointestinal tract symptoms such as heart burn/ regurgitation
Exclusion Criteria
* Participation in a clinical study(excluding non-interventional study or registry) during the last 3 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Somchai Leelasukolvong, Dr.
Role: PRINCIPAL_INVESTIGATOR
Siriraj Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Bangkok Noi, Bangkok, Thailand
Research Site
Muang, Bangkok, Thailand
Research Site
Pathumwan, Bangkok, Thailand
Research Site
Rajthevee, Bangkok, Thailand
Research Site
Ratchthewi, Bangkok, Thailand
Research Site
Maung, Changwat Khon Kaen, Thailand
Research Site
Muang, Changwat Nonthaburi, Thailand
Research Site
Klong Luang, Changwat Pathum Thani, Thailand
Research Site
Maung, Changwat Ratchaburi, Thailand
Research Site
Maung, Changwat Samut Sakhon, Thailand
Research Site
Maung, Changwat Sukhothai, Thailand
Research Site
Maung, Changwat Trang, Thailand
Research Site
Muang, Changwat Udon Thani, Thailand
Research Site
Maerim, Chiang Mai, Thailand
Research Site
Maung, Chiang Mai, Thailand
Research Site
Maung, Nakhon Sri Thammarat, Thailand
Research Site
Maung, Nakhonratchasima, Thailand
Research Site
Maung, Nakhonsawan, Thailand
Research Site
Maung, Nakornpathom, Thailand
Research Site
Maung, Phetchabun, Thailand
Research Site
Maung, Phuket, Thailand
Research Site
Maung, Roiet, Thailand
Research Site
Maung, Ubonratchathani, Thailand
Research Site
Varin Chamrap, Ubonratchathani, Thailand
Research Site
Maung, Uttaradit, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GTH-NEX-2009/1
Identifier Type: -
Identifier Source: org_study_id